|
CMO Guidance to Discuss Quality Accord Expectations: FDA Official
CINCINNATI — The FDA will issue guidance detailing what information drugmakers should share with contract manufacturing organizations (CMO) hired to work on their products, FDA officials say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives